4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0001193125-26-424421
CEO sold 50,000 shares at an average $23.77 ($1,188,745)
- CEO acquired 50,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Evans John M. · CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +25,000 | $1.03 | $25,750 | 1,072,205 | D |
| 2026-10-15 | Sale : show line 2 in the form 10b5-1 | −25,000 | $23.57 | $589,150 | 1,047,205 | D |
| 2026-10-16 | Exercise or conversion : show line 3 in the form 10b5-1 | +25,000 | $1.03 | $25,750 | 1,072,205 | D |
| 2026-10-16 | Sale : show line 4 in the form 10b5-1 | −25,000 | $23.98 | $599,595 | 1,047,205 | D |
| Open-market sales · 50,000 sh · avg $23.77 · $1,188,745 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-15 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −25,000 | 180,804 | D |
| 2026-10-16 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −25,000 | 155,804 | D |
Loading xslF345X06/ownership.xml…